SEARCH

SEARCH BY CITATION

References

  • BOEHM, S. & KUBISTA, H. (2002). Fine tuning of sympathetic transmitter release via ionotropic and metabotropic presynaptic receptors. Pharmacol. Rev., 54, 4399.
  • CHENG, Z.Q., BOSE, D., JACOBS, H., LIGHT, R.B. & MINK, S.N. (2002). Sepsis causes presynaptic histamine H3 and α2-adrenergic dysfunction in canine myocardium. Cardiovasc. Res., 56, 225234.
  • COHEN, J. (2002). The immunopathogenesis of sepsis. Nature, 420, 885891.
  • FATEHI-HASSANABAD, Z., FURMAN, B.L. & PARRATT, J.R. (1995). The effect of endotoxin on sympathetic responses in the rat isolated perfused mesenteric bed; involvement of nitric oxide and cyclo-oxygenase products. Br. J. Pharmacol., 116, 33163322.
  • GIUSTI-PAIVA, A., DE CASTRO, M., ANTUNES-RODRIGUES, J. & CARNIO, E.C. (2002). Inducible nitric oxide synthase pathway in the central nervous system and vasopressin release during experimental septic shock. Crit. Care Med., 30, 13061310.
  • GODLEWSKI, G., MALINOWSKA, B., BUCZKO, W. & SCHLICKER, E. (1997). Inhibitory H3 receptors on sympathetic nerves of the pithed rat: activation by endogenous histamine and operation in spontaneously hypertensive rats. Naunyn-Schmiedeberg's Arch. Pharmacol., 355, 261266.
  • GUHA, M. & MACKMAN, N. (2001). LPS induction of gene expression in human monocytes. Cell Signal, 13, 8594.
  • HILL, S.J., GANELLIN, C.R., TIMMERMAN, H., SCHWARTZ, J.C., SHANKLEY, N.P., YOUNG, J.M., SCHUNACK, W., LEVI, R. & HAAS, H.L. (1997). International Union of Pharmacology. XIII. Classification of histamine receptors. Pharmacol. Rev., 49, 253278.
  • HOWLETT, A.C., BARTH, F., BONNER, T.I., CABRAL, G., CASELLAS, P., DEVANE, W.A., FELDER, C.C., HERKENHAM, M., MACKIE, K., MARTIN, B.R., MECHOULAM, R. & PERTWEE, R.G. (2002). International Union of Pharmacology. XXVII. Classification of cannabinoid receptors. Pharmacol. Rev., 54, 161202.
  • JONES, S.B., KOTSONIS, P. & MAJEWSKI, H. (1994). Endotoxin enhances noradrenaline release in the rat by peripheral mechanisms. Shock, 2, 370375.
  • KLEIN, T.W., NEWTON, C.A. & FRIEDMAN, H. (2001). Cannabinoids and the immune system. Pain Res. Manage., 6, 95101.
  • LAGNEUX, C. & LAMONTAGNE, D. (2001). Involvement of cannabinoids in the cardioprotection induced by lipopolysaccharide. Br. J. Pharmacol., 132, 793796.
  • LANDRY, D.W. & OLIVER, J.A. (2001). The pathogenesis of vasodilatory shock. N. Engl. J. Med., 345, 588595.
  • LEVI, R. & SMITH, N.C.E. (2000). Histamine H3-receptors: a new frontier in myocardial ischemia. J. Pharmacol. Exp. Ther., 292, 825830.
  • LI, X., ESCHUN, G., BOSE, D., JACOBS, H., YANG, J.J., LIGHT, R.B. & MINK, S.N. (1998). Histamine H3 activation depresses cardiac function in experimental sepsis. J. Appl. Physiol., 85, 16931701.
  • MALINOWSKA, B. & SCHLICKER, E. (1991). H3 receptor-mediated inhibition of the neurogenic vasopressor response in pithed rats. Eur. J. Pharmacol., 205, 307310.
  • MALINOWSKA, B., GODLEWSKI, G., BUCHER, B. & SCHLICKER, E. (1997). Cannabinoid CB1 receptor-mediated inhibition of the neurogenic vasopressor response in the pithed rat. Naunyn-Schmiedeberg's Arch. Pharmacol., 356, 197202.
  • MALINOWSKA, B., KWOLEK, G. & GÖTHERT, M. (2001a). Anandamide and methanandamide induce both vanilloid VR1- and cannabinoid CB1 receptor-mediated changes in heart and blood pressure in anaesthetized rats. Naunyn- Schmiedeberg's Arch. Pharmacol., 364, 562569.
  • MALINOWSKA, B., PISZCZ, J., KONECZNY, B., HRYNIEWICZ, A. & SCHLICKER, E. (2001b). Modulation of the cardiac autonomic transmission of pithed rats by presynaptic OP4 and cannabinoid CB1 receptors. Naunyn-Schmiedeberg's Arch. Pharmacol., 264, 233241.
  • NIEDERHOFFER, N. & SZABO, B. (1999). Effect of the cannabinoid receptor agonist WIN55212-2 on sympathetic cardiovascular regulation. Br. J. Pharmacol., 126, 457466.
  • NIEDERHOFFER, N., SCHMID, K. & SZABO, B. (2003). The peripheral sympathetic nervous system is the major target of cannabinoids in eliciting cardiovascular depression. Naunyn-Schmiedeberg's Arch. Pharmacol., 367, 434443.
  • ORLIAC, M.L., PERONI, R., CELUCH, S.M. & ADLER-GRASCHINSKY, E. (2003). Potentiation of anandamide effects in mesenteric beds isolated from endotoxemic rats. J. Pharmacol. Exp. Ther., 304, 179184.
  • PFITZER, T. & SZABO, B. (2004). Search for an endogenous cannabinoid-mediated effect in the sympathetic nervous system. Naunyn-Schmiedeberg's Arch. Pharmacol., 369 (Suppl 1), R25.
  • RINALDI-CARMONA, M., BARTH, F., MILLAN, J., DEROCQ, J.M., CASELLAS, P., CONGY, C., OUSTRIC, D., SARRAN, M., BOUABOULA, M., CALANDRA, B., PORTIER, M., SHIRE, D., BRELIÈRE, J.C. & LE FUR, G. (1998). SR 144528, the first potent and selective antagonist of the CB2 receptor. J. Pharmacol. Exp. Ther., 284, 644650.
  • SCHLICKER, E., URBANEK, E. & GÖTHERT, M. (1989). ATP, α,β-methylene ATP and suramin as tools for the characterization of vascular P2x receptors in the pithed rat. J. Autonom. Pharmacol., 9, 357366.
  • STREEFKERK, J.O., MATHY, M.J., PFAFFENDORF, M. & VAN ZWIETEN, P.A. (2002). Vasopressin-induced presynaptic facilitation of sympathetic neurotransmission on the pithed rat. J. Hypertens., 20, 11751180.
  • TAKAKURA, K., GOTO, Y., KIGOSHI, S. & MURAMATSU, I. (1994). Selective inhibition of sympathetic nerve-mediated contraction by L-arginine in lipopolysaccharide-treated tail artery in rats. Eur. J. Pharmacol., 271, 367370.
  • TARPEY, S.B., BENNETT, T., RANDALL, M.D. & GARDINER, S.M. (1998). Differential effects of endotoxemia on pressor and vasoconstrictor actions of angiotensin and arginine vasopressin in conscious rats. Br. J. Pharmacol., 123, 13671374.
  • VARGA, K., WAGNER, J.A., BRIDGEN, D.T. & KUNOS, G. (1998). Platelet- and macrophage-derived endogenous cannabinoids are involved in endotoxin-induced hypotension. FASEB J., 12, 10351044.
  • VINCENT, J.L. (1998). Cardiovascular alterations in septic shock. J. Antimicrob. Chemother., 41 (Suppl A), 915.
  • WAGNER, J.A., HU, K., BAUERSACHS, J., KARCHER, J., WIESLER, M., GOPARAJU, S.K., KUNOS, G. & ERTL, G. (2001). Endogenous cannabinoids mediate hypotension after experimental myocardial infarction. J. Am. Coll. Cardiol., 38, 20482054.
  • WAGNER, J.A., VARGA, K. & KUNOS, G. (1998). Cardiovascular actions of cannabinoids and their generation during shock. J. Mol. Med., 76, 824836.
  • WAGNER, J.A., VARGA, K., ELLIS, E.F., RZIGALINSKI, B.A., MARTIN, B.R. & KUNOS, G. (1997). Activation of peripheral CB1 canna-binoid receptors in haemorrhagic shock. Nature, 390, 518521.
  • ZYGMUNT, P.M., PETERSSON, J., ANDERSSON, D.A., CHUANG, H., SORGARD, M., DI MARZO, V., JULIUS, D. & HÖGESTÄTT, E.D. (1999). Vanilloid receptors on sensory nerves mediate the vasodilator action of anandamide. Nature, 400, 452457.